HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Familial Mediterranean fever responds well to infliximab: single case experience.

Abstract
The most common arthritic involvement in familial Mediterranean fever (FMF) is acute recurrent monoarthritis; however, sometimes spondyloarthropathy-like findings or typical ankylosing spondylitis may also ensue. Reported here is our favorable experience with infliximab in an FMF patient who had been resistant to colchicine and disease-modifying antirheumatic drugs (sulfasalazine and methotrexate) treatments. A 72-week follow-up of the patient yielded complete remission of the febrile abdominal episodes, and spondylitis responded well. The patient's bilateral aseptic necrosis of the femoral head deteriorated and caused hip pain, discomfort, and disability. Overall, we believe that tumor necrosis factor (TNF) alpha has an important role in the disease pathogenesis and also that anti-TNF may represent a promising robust treatment alternative in FMF.
AuthorsSalih Ozgocmen, Levent Ozçakar, Ozge Ardicoglu, Ercan Kocakoc, Arzu Kaya, Adem Kiris
JournalClinical rheumatology (Clin Rheumatol) Vol. 25 Issue 1 Pg. 83-7 (Feb 2006) ISSN: 0770-3198 [Print] Germany
PMID16172948 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antibodies, Monoclonal
  • Gastrointestinal Agents
  • Tumor Necrosis Factor-alpha
  • Infliximab
Topics
  • Adult
  • Antibodies, Monoclonal (therapeutic use)
  • Familial Mediterranean Fever (drug therapy)
  • Female
  • Femur Head Necrosis (drug therapy, pathology, physiopathology)
  • Gastrointestinal Agents (therapeutic use)
  • Humans
  • Infliximab
  • Magnetic Resonance Imaging
  • Spine (pathology)
  • Spondylitis (drug therapy, pathology, physiopathology)
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha (antagonists & inhibitors)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: